The new weight-loss drugs Wegovy and Zepbound are in high demand, and the clamoring will only increase in coming years, experts predict. That’s because drugs like these, which rely at least in part on the appetite-regulating hormone GLP-1, are being investigated not just for weight loss and diabetes, but also for a wide range of other conditions. “Weight loss is only part of it,” says Dr. Ian Neeland, chair of the American Heart Association’s obesity science committee and an associate professor of medicine at Case Western Reserve University. [time-brightcove not-tgx=”true”] Here’s the latest (and still-growing) list. Heart disease In March, the U.S. Food and Drug Admini
Hence then, the article about scientists are studying weight loss drugs for way more than weight loss was published today ( ) and is available onTime ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Scientists Are Studying Weight-Loss Drugs for Way More Than Weight Loss )